The Roles of DEA and FDA in the Cannabis Legalization Process
Listen now
Description
Stanley Jutkowitz, Senior Counsel with Seyfarth Shaw LLP discusses the recent DEA decision to reschedule cannabis from schedule one to schedule three, with potential less restrictive schedules. Stanley provided legal insights on the implications of this move, while highlighting the controversy surrounding cannabis legalization and rescheduling. We also explored the roles of DEA and FDA in the legalization process, emphasizing the complexity of the legal landscape with multiple agencies involved and conflicting treaty obligations and federal laws. We also discussed regulatory challenges and legal implications of cannabis, including the distinction between hemp and marijuana, taxation and decriminalization, and the current state of legalization and regulation in the US. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
More Episodes
In this episode of Grassroots Marketing, we interview Dan Mondello, CEO and Co-Founder of Rank Really High, about the transformative potential of the Joint E-commerce Platform for the cannabis industry. Dan highlights how this seamless and integrated solution outperforms traditional methods like...
Published 06/17/24
Published 06/17/24
Grassroots Marketing interviews James Krouse, Founder and CEO of Flower Power Genetics. James delves into the creation of "Adam," a hybrid cannabis strain developed from vintage seeds stored for over 30 years. This strain, a cross between a tropical Sativa and an Indica from the Middle East, aims...
Published 06/17/24